Red Light Therapy for Hip Pain (2026 Guide)

The hip is a deep joint. That is both a mechanical asset (the ball-and-socket geometry provides inherent stability that the knee and shoulder lack) and a treatment challenge. Most of the structures that become painful in hip conditions, the labrum, the articular cartilage, the femoral head, the acetabular rim, sit 4 to 8cm below the skin surface depending on soft tissue thickness. This depth separates what photobiomodulation can reliably reach from what it cannot, and being clear about that boundary is the foundation of a useful treatment approach.

The hip deserves its own look because the depth issue gets used as a reason to dismiss photobiomodulation here, and that dismissal is partly wrong. Near-infrared does not reach the deepest hip structures with the same irradiance it delivers to a superficial joint. But the conditions responsible for most hip pain do not all live at maximum depth. Greater trochanteric pain syndrome, the most common hip pain diagnosis in adults between 40 and 60, arises from the gluteal tendons and bursa at the lateral hip surface. That tissue is far more accessible than the central joint. Hip flexor tendinopathy sits anteriorly, relatively close to the skin. The periarticular soft tissue surrounding the hip joint responds to treatment even when the joint surface itself is at the limits of effective penetration.

This guide covers what photobiomodulation realistically does and does not do for hip pain, which conditions respond well, how to structure a protocol, and which devices suit the anatomy. It is direct about where the depth limits matter, because overselling near-infrared's reach into the hip joint leads to disappointment. Within the right expectations, there is a genuine case for daily photobiomodulation in hip pain management.

Why Hip Pain Is Different from Knee or Shoulder Pain

Three factors distinguish the hip from other joints that photobiomodulation treats well.

First, depth. The femoral head and acetabular cartilage in a person with typical soft tissue thickness sit roughly 4 to 7cm below the anterior hip surface. Near-infrared light at 850nm delivers meaningful irradiance to approximately 3 to 5cm in most tissues. This means the central articular surface of the hip is at the effective boundary of near-infrared penetration, while the surrounding periarticular structures, tendons, bursae, and muscle-tendon junctions, are well within range. Photobiomodulation for hip osteoarthritis is working primarily on the periarticular inflammation and the subchondral bone rather than directly on the articular cartilage itself. That still matters, but it is worth being clear about what is being treated.

Second, anatomical complexity. The hip has anterior, posterior, medial, and lateral aspects, each with distinct structures. Greater trochanteric pain (lateral hip) involves gluteal tendons and the trochanteric bursa. Anterior hip pain involves the hip flexors, iliopsoas bursa, and the femoral nerve territory. Posterior hip pain involves the deep external rotators, the sciatic nerve territory, and the piriformis. These are different conditions requiring different placements. Treating "the hip" without knowing which aspect is symptomatic produces inconsistent results.

Third, load. The hip bears body weight in stance, walking, climbing, and descending stairs. Unlike the shoulder, you cannot meaningfully offload it without altering gait mechanics. This sustained mechanical demand means healing is perpetually interrupted by the next step. Any intervention that accelerates the cellular repair cycle between loading events matters more in weight-bearing joints than in the upper limb.

How Red Light Therapy Works in Hip Tissue

Synovial and Periarticular Inflammation

Hip osteoarthritis involves inflammation of the synovial membrane and the soft tissue surrounding the joint. The synovium produces cytokines, including IL-1beta, TNF-alpha, and IL-6, that damage cartilage matrix, sensitize joint nociceptors, and drive the pain that limits movement. Even when articular cartilage has been substantially lost, treating the surrounding inflammatory environment matters for pain control and for slowing progression of the remaining cartilage.

Photobiomodulation reduces pro-inflammatory cytokine production in synovial tissue through its effects on mitochondrial function and downstream signaling. The synovial lining wraps around the joint periphery and periarticular tissue, much of which is within practical treatment depth from the anterior and lateral hip surfaces. Reducing the inflammatory load in the joint space reduces pain sensitization even when the structural damage is not reversed.

Gluteal Tendon and Trochanteric Bursal Pathology

The gluteal tendons (gluteus medius and gluteus minimus) insert on the greater trochanter, and their pathology is now understood as tendinopathy rather than pure bursitis in most cases. The trochanteric bursa does become inflamed, but it is usually a secondary response to the underlying tendinopathy. This distinction matters because it changes the treatment target. Photobiomodulation for gluteal tendinopathy works through the same fibroblast and tenocyte mechanisms documented for rotator cuff and patellar tendons: improved collagen synthesis, reduced neurogenic inflammation, better local oxygenation in tissue with poor intrinsic blood supply.

The gluteal tendon insertion on the greater trochanter sits at the lateral hip surface. There is less tissue between skin and tendon here than there is between skin and femoral head. Near-infrared penetrates this anatomy effectively, and the tendinopathy mechanism responds well to the photobiomodulation stimulus. For people with lateral hip pain who have had cortisone injections that provided temporary relief but not lasting resolution, photobiomodulation offers ongoing management that targets the tissue biology rather than suppressing it.

Hip Flexor and Anterior Capsular Tissue

For the iliopsoas tendon, which crosses the anterior hip joint and inserts on the lesser trochanter, anterior placement covers the proximal tendon and its relationship with the iliopsoas bursa. Anterior hip pain that worsens with hip flexion against resistance, prolonged sitting, or standing from a low seat suggests iliopsoas involvement, and this is a treatable target. The anterior hip is more accessible than the lateral for intra-articular structures, and the anterior capsule of the hip joint responds to periarticular photobiomodulation in the same way other joint capsules do: reduced capsular inflammation, improved tissue extensibility, reduced stiffness after rest.

Subchondral Bone and Cartilage Metabolism

Near-infrared reaches the peripheral acetabular cartilage and femoral head with meaningful irradiance, though the central articular surface is at the practical penetration limit in many people. What it reaches more consistently is the subchondral bone, which is a significant pain source in hip OA. Bone marrow lesions, areas of altered bone metabolism and local edema in the subchondral bone, correlate with pain intensity in osteoarthritis and respond to interventions that improve local bone vascularity and metabolism.

Photobiomodulation stimulates osteoblast activity and supports local bone metabolism through its mitochondrial mechanisms. In the subchondral bone of a hip with OA, this contributes to reduction in the bone-mediated pain component. It is not cartilage regeneration. But for many people with hip OA, the bone component of their pain responds to this in a way they did not expect from something applied superficially to the outer hip.

Deep Gluteal Muscle and Nerve Tissue

The piriformis and deep external rotators are involved in a subset of hip and posterior thigh pain presentations. Piriformis syndrome, where the piriformis muscle irritates the sciatic nerve, produces pain patterns that can mimic lumbar disc pathology but originate locally at the posterior hip. The piriformis sits deeper than the gluteal tendons, but photobiomodulation penetrates into the posterior hip musculature and reduces the inflammatory component of muscular irritation affecting adjacent neural structures. Posterior gluteal placement covers this anatomy when posterior hip pain or buttock symptoms are the primary complaint.

See NovaaLab Devices for Hip Pain

Conditions with the Strongest Evidence

Greater Trochanteric Pain Syndrome

This is where the evidence is most directly applicable and the treatment anatomy most favorable. Greater trochanteric pain syndrome, formerly called trochanteric bursitis, is the most common hip pain diagnosis in adults between 40 and 60, and women develop it roughly four times as often as men. The lateral hip pain that worsens with side-lying, climbing stairs, or walking on uneven ground is characteristic. It is a frustrating condition because it does not respond well to rest (the tendons are under load every time you take a step) and recurs frequently after conservative management.

The gluteal tendon insertion on the greater trochanter is superficially accessible from the lateral hip surface. Near-infrared penetrates this anatomy effectively. The tendinopathy mechanism, disorganized collagen repair, local hypoxia, neurogenic sensitization, responds to the same photobiomodulation mechanisms documented in rotator cuff and Achilles tendinopathy, both of which have solid research bases. The evidence for photobiomodulation in tendinopathy broadly, applied to the lateral hip anatomy, makes this the most defensible hip application.

Hip Osteoarthritis

Hip OA has a smaller research base for photobiomodulation than knee OA, but the studies that exist show consistent patterns. Randomized controlled trials have found that low-level laser therapy reduces pain and improves function in hip osteoarthritis compared to sham, with effects on pain intensity during movement and on functional outcomes including walking distance and stair-climbing ability. The depth limitation means the treatment is working primarily on periarticular inflammation, subchondral bone metabolism, and surrounding soft tissue rather than the articular surface. That is still clinically meaningful: pain reduction and improved function are the outcomes that matter.

The evidence is stronger for photobiomodulation combined with physical therapy than for photobiomodulation alone. Hip OA management that includes exercise, movement, and load management benefits from the cellular support photobiomodulation provides between sessions. The combination consistently outperforms either intervention in isolation in studies that have compared them.

Hip Flexor Strain and Iliopsoas Tendinopathy

Anterior hip pain from iliopsoas strain or chronic tendinopathy is common in runners, cyclists, and people who sit for extended periods with a flexed hip posture. The snapping sensation with hip flexion (sometimes called snapping hip syndrome) often accompanies iliopsoas tendinopathy. The anterior thigh and groin discomfort that worsens after running or prolonged sitting represents the chronic tendinopathy pattern that responds to photobiomodulation through the same mechanisms as other tendinopathies.

Anterior placement over the hip crease, where the thigh meets the torso, targets the proximal iliopsoas, the iliopsoas bursa, and the anterior capsule of the hip joint. For more medially distributed groin pain, positioning the device slightly more medial covers the relevant anatomy. This is one of the more straightforward hip applications because the anterior hip structures are more accessible than the deep joint.

Post-Surgical Hip Recovery

Hip replacement and hip labral repair both involve significant soft tissue trauma and a rehabilitation arc measured in months. Photobiomodulation in the early post-surgical period supports the same biological processes documented in other post-surgical applications: reduced inflammatory burden at the repair site, faster wound healing, improved collagen organization in healing tissue, and reduced post-operative edema. For hip replacement specifically, the photobiomodulation is applied to the soft tissue above the prosthesis (anterior or posterior approach depending on surgical access), not through metal. Metal components scatter and absorb light rather than transmitting it, so the target is periarticular soft tissue.

The practical window for maximum effect is the first 6 to 8 weeks post-surgery, when the repair site biology is most active. Most surgeons are supportive of photobiomodulation in the rehabilitation phase. The standard guidance is to wait until the incision is closed before applying photobiomodulation directly over the surgical site, and to confirm clearance at your follow-up appointment.

See the Novaa Deep Healing Pad for Hip Treatment

Protocol for Hip Pain

Wavelength Selection

Near-infrared (850nm) is the primary wavelength for hip conditions. The depth requirement for reaching even periarticular structures at the hip means red light (660nm), with its shorter effective penetration range, contributes less here than it does for superficial conditions. The combination of red plus near-infrared that most NovaaLab pad devices deliver is fine. You get the superficial tissue effects from red alongside the deeper penetration of near-infrared. But if using a device with adjustable settings, bias heavily toward near-infrared for hip treatment. This is one application where the wavelength choice matters more than it does for a superficial skin or muscle target.

Placement and Coverage

Placement depends entirely on where the pain is located:

Lateral hip pain (greater trochanteric pain syndrome, IT band-related lateral hip pain): position the pad directly over the greater trochanter, the bony prominence you can feel on the outer thigh roughly a hand's width below the hip crest. Extend coverage slightly superior and inferior to catch the full length of the gluteal tendon insertion and the adjacent bursa.

Anterior hip pain (hip flexor, iliopsoas, anterior capsule): position the pad over the anterior hip crease where the thigh meets the torso. For groin-pattern pain, move slightly more medial and inferior toward the femoral triangle.

Diffuse hip OA pain without a clear focal point: a two-placement approach covering both the lateral hip and the anterior hip in the same session covers the most territory. The anterior placement treats periarticular tissue and the anterior capsule. The lateral placement treats the greater trochanter and gluteal tendon territory.

Posterior hip and buttock pain (piriformis involvement, deep gluteal syndrome, sciatica-pattern posterior hip pain): posterior gluteal placement over the piriformis region, roughly at the midpoint of the posterior hip just lateral to the sacrum.

Session Duration and Dosing

15 to 20 minutes per placement is appropriate for hip treatment. The depth requirement for hip conditions means longer sessions are more relevant here than for superficial targets: more time at the surface allows more accumulated photons to penetrate to depth. If treating two placements in the same session (anterior and lateral), 15 minutes each is a reasonable protocol. Most NovaaLab pad devices are calibrated to deliver therapeutic doses within a 20-minute session, which is the designed treatment time. This is one application where running the full 20 minutes rather than cutting short at 15 is worth doing consistently.

Frequency

Daily sessions give the best outcomes for active hip conditions. Greater trochanteric tendinopathy and hip OA are both chronic conditions where the tissue is perpetually being loaded between sessions, so maintaining consistent cellular signaling across daily treatment builds cumulative effects faster than every-other-day protocols. For the first 6 weeks, daily is the right frequency. Once pain has substantially stabilized, stepping to 5 sessions per week for maintenance is reasonable. Going below 3 sessions per week during active treatment loses the cumulative cellular benefit that drives the tissue changes.

Timing for Maximum Effect

Treating in the evening places the cellular repair activity in the overnight rest window, when the hip is unloaded during sleep. This is the optimal timing for weight-bearing joint conditions: photobiomodulation kicks off the tissue repair signals, and then the joint gets 7 to 8 hours of relative rest in which those signals drive repair without being interrupted by the next step. Morning treatment is second choice. For people with severe hip OA morning stiffness, a 10-minute morning session before getting up and loading the joint can reduce startup stiffness, and works best as a complement to the primary evening session rather than a replacement for it.

See the Deep Healing Pad XL for Full Hip Coverage

Device Recommendations for Hip Pain

The hip's anatomy requires a pad device large enough to cover the treatment zone without requiring precise repositioning or manual holding throughout the session. A small pad requires multiple placements to cover what a larger device handles in one. For the anterior hip, a medium-format device is adequate. For the lateral hip, particularly the greater trochanteric region where the treatment zone extends over the tendon insertion, a larger format pays off. Flexible pads that conform to the contour of the outer hip are practical for this anatomy.

Best for Most Hip Presentations: Novaa Deep Healing Pad

The Novaa Deep Healing Pad is the right starting point for greater trochanteric pain syndrome, hip flexor tendinopathy, and hip OA with a primary lateral or anterior pain pattern. Its flexible format drapes over the contour of the outer hip without needing to be held in place, and the treatment area is large enough to cover the greater trochanter and surrounding gluteal tendon territory in a single placement. Secure it with a light elastic bandage or athletic wrap for hands-free sessions. For most hip pain presentations with a defined location, this is the correct tool.

Check Novaa Deep Healing Pad Price

Best for Full Hip Coverage or Combined Hip and Lower Back: Novaa Deep Healing Pad XL

For hip OA where you want to cover the lateral, anterior, and superior hip in one placement, or for larger individuals where the standard pad does not reach the full treatment zone, the Novaa Deep Healing Pad XL provides more coverage per session. It also suits people who need simultaneous hip and lower back coverage: the XL is large enough to straddle the hip-lumbar junction for combined sessions, which matters for people with coexisting lumbar and hip pathology where the pain patterns overlap. Post-surgical hip recovery, where the treatment zone includes both the incision area and surrounding musculature, benefits from the broader coverage as well.

Check Deep Healing Pad XL Price

What to Expect: Realistic Timeline

For greater trochanteric pain syndrome, the first noticeable change is usually a reduction in the lateral hip tenderness that makes side-lying uncomfortable. This tends to appear within 2 to 3 weeks of daily sessions. The pain on weight-bearing, particularly on stairs and single-leg loading, improves more gradually over 4 to 8 weeks. Full resolution, meaning comfortable function across normal daily activities without lateral hip soreness, typically takes 8 to 12 weeks of consistent daily treatment combined with load management. Avoiding compressive positions like crossing the legs, deep hip flexion in low seats, and prolonged pressure on the lateral hip gives the treatment room to accumulate without competing against continuous irritation of the tendon. Photobiomodulation is doing the cellular work. Load management is providing the conditions for that work to take hold.

Hip OA has a longer and more variable timeline. Pain reduction is the first improvement, often noticeable at 3 to 4 weeks of daily sessions. Functional improvements follow: better walking distance, less morning stiffness, easier stairs. The underlying joint pathology does not reverse, but the inflammatory component driving pain and function limitation responds to treatment in a way that produces real gains. Those gains require ongoing treatment to sustain. Stopping entirely after improvement typically means gradual return of symptoms over weeks to months, so hip OA particularly benefits from a long-term maintenance protocol rather than a finite course followed by complete cessation.

Post-surgical hip recovery follows the wound healing timeline: the first 4 to 6 weeks see the most dramatic response, when the proliferative phase of wound healing is most active. The aim is less post-surgical stiffness and a faster return of comfortable range of motion. Check with the surgical team first. The joint biology, bone integration and capsule healing, follows its own timeline that photobiomodulation does not override. What it improves is the soft tissue component, which is often the limiting factor in the early rehabilitation phase.

Frequently Asked Questions

Can red light therapy actually reach the hip joint?

Near-infrared at 850nm reaches the peripheral articular tissue and subchondral bone of the hip in most people. The central articular surface of the femoral head and acetabulum sits at the effective penetration limit for most devices, particularly in people with more soft tissue. What photobiomodulation reliably reaches is the synovial tissue, periarticular bursa, tendon insertions, and subchondral bone. For most hip pain conditions, these are the primary pain generators, so the depth limitation is less of a practical obstacle than it sounds in theory. Greater trochanteric pain syndrome in particular has favorable anatomy because the relevant structures are at the lateral hip surface, not deep in the joint.

I have a hip replacement. Can I use red light therapy?

Yes, with the right approach. Light does not transmit through the metal components of a hip prosthesis, so you are treating the soft tissue surrounding the prosthesis rather than anything through the prosthetic components themselves. Post-surgical periarticular inflammation, scar tissue, and gluteal muscle deficits following hip replacement all respond to photobiomodulation the same way they would in a non-replaced hip. Position the device over the surrounding soft tissue. Most surgeons have no objection. Confirm at your follow-up appointment before starting if you are early in your post-surgical recovery.

I was told I have a hip labral tear. Will this help?

The labrum sits deep in the hip joint, at the acetabular rim, which is at or beyond the practical penetration limit for photobiomodulation in most people. Photobiomodulation is unlikely to directly affect the labral tissue itself. What it can address is the periarticular inflammation that accompanies labral pathology, the hip flexor and capsular irritation that develops secondary to labral instability, and post-surgical inflammation after labral repair. Managing the inflammatory environment around the joint reduces pain and improves function even when the labral structural issue is not directly treated. If you are considering labral repair surgery, photobiomodulation in the pre-surgical phase supports the surrounding tissue going into surgery, and in the post-surgical phase it supports soft tissue recovery.

My hip pain is in the groin. Is that the same as other hip pain?

Groin pain from the hip is usually anterior hip joint pathology, iliopsoas tendinopathy, or adductor-related strain, each requiring different treatment placement. True hip joint pain often refers to the groin rather than the lateral hip, because the anterior capsule is a primary pain-generating structure in femoroacetabular impingement and early hip OA. For groin-pattern hip pain, anterior placement is the correct approach. For lateral hip pain, lateral placement over the greater trochanter is appropriate. If the pain has features of adductor strain (worsening with resisted hip adduction, tenderness along the inner thigh), the treatment zone moves further medial and distal. Identifying which pattern fits your pain guides the placement decision more than any general "treat the hip" instruction does.

How does red light therapy for hip pain compare to cortisone injections?

Cortisone injections work faster for an acute severe flare, particularly for trochanteric bursitis or hip OA flare-ups. An intra-articular hip injection or peritrochanteric injection suppresses the acute inflammatory response within 48 to 72 hours and provides meaningful pain relief in most cases. The limitation is duration and cumulative effect: relief is temporary, typically lasting weeks to a few months, and repeated injections into tendons carry risks of tendon weakening and accelerated degeneration. Photobiomodulation provides ongoing cellular support without those risks and addresses the underlying tissue biology rather than suppressing it. For someone in a severe acute flare, a single injection to break the acute cycle followed by photobiomodulation for ongoing management is a sensible combination. They work through different mechanisms and are complementary rather than competing.

Is red light therapy safe over a metal hip implant?

Yes. Near-infrared light does not cause heating or any harmful reaction in metal implants at normal therapeutic intensities. The light does not transmit through the metal, which means the prosthesis is opaque to the treatment and you are treating the surrounding soft tissue. The same precautions apply as for anyone post-surgery: avoid direct application over a fresh incision until it is closed, and confirm with your orthopedic surgeon if you have any device-specific concerns. The interaction between photobiomodulation and common orthopedic implant materials (titanium, cobalt-chromium alloys) at therapeutic intensities is not harmful.

Final Thoughts

Hip pain covers a wide range of conditions with different anatomical targets, and photobiomodulation's relevance varies across them. For greater trochanteric pain syndrome, the anatomy is favorable, the tendinopathy mechanism matches what photobiomodulation addresses, and the broader evidence for tendon photobiomodulation is solid. This is the hip condition most likely to respond clearly and predictably to daily treatment. For hip OA, the depth challenge is real but periarticular inflammation and subchondral bone metabolism are legitimate treatment targets that produce genuine pain reduction in many people. Post-surgical hip recovery benefits during the soft tissue healing phase. Deeper intra-articular pathology, labral tears and severe cartilage loss, is where the treatment's limits are most apparent.

What makes photobiomodulation worth adding to a hip pain management plan is that it addresses something the standard toolkit does not: the cellular repair environment between loading events. Physical therapy gives the mechanical stimulus. NSAIDs and cortisone suppress the inflammatory response. Photobiomodulation improves the metabolic conditions in which tissue repair happens, which is a different lever on the same problem. For chronic hip conditions where tissue turnover is slow and healing is perpetually interrupted by loading, providing better working conditions for the cells doing the repair work is not a minor contribution.

NovaaLab's 60-day money-back guarantee is long enough for a proper trial. Six weeks of daily sessions gives a clear answer on whether photobiomodulation is reducing your specific hip pain pattern. Track the relevant metrics each week: morning stiffness duration, pain level on stairs, lateral hip soreness when side-lying. Those concrete observations tell you whether the treatment is working for your presentation without relying on a vague sense of whether things feel different. Run the trial at daily frequency and full session length, and you get real data rather than a guess.

Try NovaaLab Risk-Free for 60 Days